false
Catalog
Clozapine and the Gastrointestinal Tract
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is a summary of a presentation on the topic of clozapine and its effects on the gastrointestinal tract. Clozapine is an antipsychotic medication commonly used to treat serious mental illnesses. The presentation emphasizes the importance of recognizing and managing gastrointestinal complications associated with clozapine.<br /><br />The presenter discusses the Clinical Support System for Serious Mental Illness (CSS-SMI), an initiative funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and implemented by the American Psychiatric Association (APA).<br /><br />The presentation highlights the case of a patient named Kate who experienced serious complications, including bowel obstruction and aspiration pneumonia, as a result of clozapine-induced gastrointestinal hypomotility (CIGH). This case illustrates the potential dangers of CIGH and emphasizes the need for vigilance in monitoring and managing constipation in patients taking clozapine.<br /><br />The presentation outlines the five "S"s of CIGH: slow gut, significant gastrointestinal hypomotility, often silent symptoms, and serious complications. It discusses the prevalence of constipation and slow gut in patients taking clozapine and highlights the importance of early detection and intervention to prevent serious complications.<br /><br />The presentation also provides recommendations for managing constipation in patients taking clozapine, including using laxatives, minimizing anticholinergic load, and considering the use of the Porirua Protocol, a treatment approach specifically designed for patients with clozapine-induced gastrointestinal hypomotility.<br /><br />Overall, the presentation underscores the need for healthcare professionals to be aware of the gastrointestinal effects of clozapine and to take proactive measures to monitor and manage constipation in affected patients.
Keywords
clozapine
gastrointestinal tract
antipsychotic medication
gastrointestinal complications
bowel obstruction
aspiration pneumonia
constipation
slow gut
early detection
healthcare professionals
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English